NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/20/2026
Back to search
Official data from USPTO
DUVYZAT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
01/20/2026
Trademark type
Combined
Nice classes
5
Filing date
03/18/2024
Registration date
01/20/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/20/2026
Last transaction
01/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/25/2024
First use in commerce
07/25/2024
Drawing code
3
Owner type
99
Owner location
Milano, IT
Examiner
NELMAN, JESSE M
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a set of colored boxes and one circle ranging in color from blue to purple to green, and in size from large to small starting on the right side and arching over the letters "DUV" in the stylized word element "DUVYZAT" in blue, with the final design element being a green circle above the letter "V".
Holders and representatives
Holders
ITALFARMACO S.P.A.
Representatives
John Pickerill FREDRIKSON & BYRON, P.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biochemical and chemical preparations for medical usechemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseasesinflammatory diseasesHIV/AIDSspinal muscular atrophysystemic juvenile idiopathic arthritispolycythaemia veraessential thrombocythemialeukemiasmyelomasmyelofibrosisDuchenne muscular dystrophyBecker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/20/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/29/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/29/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/27/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/26/2025
IUAF
USE AMENDMENT FILED
06/24/2025
EISU
TEAS STATEMENT OF USE RECEIVED
06/24/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/24/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2024
PUBO
PUBLISHED FOR OPPOSITION
11/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/02/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/26/2024
GNRT
NON-FINAL ACTION E-MAILED
09/26/2024
CNRT
NON-FINAL ACTION WRITTEN
09/26/2024
DOCK
ASSIGNED TO EXAMINER
09/26/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/21/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/12/2024
NWAP
NEW APPLICATION ENTERED
03/18/2024
Continuous trademark protection
Get notified about every new filing that threatens DUVYZAT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.